DUOPHARMA BIOTECH BERHAD
KLSE (MYR): DPHARMA (7148)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.15
Today's Change
-0.01 (0.86%)
Day's Change
1.14 - 1.16
Trading Volume
258,800
Financial
T4Q
31-Mar-2021
2020
31-Mar-2021
2019
31-Mar-2021
2018
31-Mar-2021
2017
31-Mar-2021
Total assets
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current assets
238
1000
110
900
600
Cash & equivalents
238
1000
110
900
600
Short term investments
238
1000
110
900
600
Total receivables, net
238
1000
110
900
600
Accounts receivable - trade, net
238
1000
110
900
600
Other receivables
238
1000
110
900
600
Total inventory
238
1000
110
900
600
Inventories - work in progress
238
1000
110
900
600
Inventories - progress payments & other
238
1000
110
900
600
Inventories - finished goods
238
1000
110
900
600
Inventories - raw materials
238
1000
110
900
600
Total non-current assets
238
1000
110
900
600
Long term investments
238
1000
110
900
600
Note receivable - long term
238
1000
110
900
600
Investments in unconsolidated subsidiaries
238
1000
110
900
600
Other investments
238
1000
110
900
600
Net property/plant/equipment
238
1000
110
900
600
Gross property/plant/equipment
238
1000
110
900
600
Accumulated depreciation, total
238
1000
110
900
600
Deferred tax assets
238
1000
110
900
600
Net intangible assets
238
1000
110
900
600
Other current assets, total
238
1000
110
900
600
Total liabilities
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current liabilities
-238
-1000
-110
-900
-600
Total non-current liabilities
-238
-1000
-110
-900
-600
Long term debt
238
1000
110
900
600
Long term debt excl. lease liabilities
238
1000
110
900
600
Capital and operating lease obligations
238
1000
110
900
600
Provision for risks & charge
-238
-1000
-110
-900
-600
Deferred tax liabilities
-238
-1000
-110
-900
-600
Other liabilities, total
-238
-1000
-110
-900
-600
Total equity
-238
-1.64%
-1000
+11.55%
-110
+81.66%
-900
-13.16%
-600
+235.36%
Total liabilities & shareholders' equities
238B
1000B
110B
900B
600B
Total debt
238
1000
110
900
600
Book value per share
-238
-1000
-110
-900
-600
Discussions
13 people like this. Showing 50 of 12,425 comments
Tmr up, those that trapped at high better sell after gap up, other people who bought at bottom want to top up.
2023-02-23 21:05
Pharma's problems are, 1) RM600mil worth of Covid vaccines expiring soon, 2) their short term debt stands at almost RM1bil.
Dpharma doesn't have both those problems.
2023-02-28 17:23
QR is out :
net profit rose 11.54% to RM22.63 million for 1QFY2023, from RM20.29 million a year earlier, on the back of higher revenue amid increased sales to the prescription pharmaceutical market. Earnings per share improved to 2.38 sen, from 2.19 sen in 1QFY2022, Quarterly revenue grew 7.82% to RM200.48 million from RM185.94 million.
2023-05-23 05:53
Got 21mil profit but share price not moving. Volume so low.
No sesy sesy stories share price how to fly? Last time got vaccine story. Now?
2023-05-23 13:49
[转贴] [Video:浅谈DUOPHARMA BIOTECH BERHAD, DPHARMA, 7148] - James的股票投资James Share Investing
https://klse.i3investor.com/web/blog/detail/general/2023-08-12-story-h-242875199
2023-08-12 21:08
Quarter results already reflected in the price before the release of the Q2 report
2023-08-25 11:37
Managed and operated by white haired people sitting in wheel chairs and using walking sticks. Most have prostate problems, waking few times at night to urinate. Some are waiting for stairways to Heavens........HOW COULD COMPANY BE AGGRESSIVE???
2023-10-08 13:10
3Q23 profits down 45% YoY....current BOD is a team of silver haired centennials in wheelchairs. Raising 2 Billion bonds for retirement benefits?
BOD too aggressive is bad, weak BOD is also bad.......take your pick.
2023-11-10 12:07
Pharma is dying, yet this ctnr with Management in wheelchairs cannot take advantage.
2023-12-02 09:04
This is just reaction to Covid case spike, after that fall back down. Nothing new and exciting on the horizon for pharma in the coming months especially when Pharmaniaga still in the dump and government cutting back on spending.
2023-12-15 16:03
Hope this collaboration can bring good revenue to the company for Fy2024 and so on
https://theedgemalaysia.com/node/692365
2024-01-15 17:14
Duopharma Biotech Bhd is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.
https://www.thestar.com.my/business/business-news/2024/01/26/duopharma-earnings-set-to-improve-this-year
2 months ago
This is my trading call dated 15 Dec 2020. Most of the time chart will tell the true story:
https://www.tradingview.com/chart/DPHARMA/5tKe08jN-Trend-Analysis/
For investment or trading ideas, please feel free to visit my chart gallery:
https://www.tradingview.com/u/Yang358/#published-charts
2 months ago
I love astronomy so most of my calculation/logics actually somehow related to astrophysics and planetary orbit. Something to do with price resistance, time resistance and speed resistance.
2 months ago
Post a Comment
Featured Posts
MQ Trading Signals
Time
Signal
Duration
Type
2024-04-19 16:45:00
EMA 5
5 Mins
SELL
2024-04-19 16:35:00
TURTLE SYSTEM 20
5 Mins
SELL
2024-04-19 16:05:00
EMA 5
5 Mins
BUY
2024-04-19 16:05:00
TURTLE SYSTEM 20
5 Mins
BUY
2024-04-19 16:00:00
EMA 5
10 Mins
BUY
Apps
Top Articles
2
3
4
Koon Yew Yin's Blog
5
Good Articles to Share
Slower US Fed pivot weakens rate-cut bets across emerging Asia
6
7
Good Articles to Share
8
Good Articles to Share
Bank of America CEO talks earnings, consumer spending, and inflation
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pang72
DPHARMA up too..
But, I don't hv..
Because glc link.
.
2022-12-21 11:57